VERU INC. Adjustments to Additional Paid in Capital, Other
VERU INC. (VERU) reported Adjustments to Additional Paid in Capital, Other of $101.98 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2019-12-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2019-12-12
- VERU INC. adjustments to additional paid in capital, other for the quarter ending 2019-06-30 was $101.98K, a 80.00% increase year-over-year.
- VERU INC. adjustments to additional paid in capital, other for the quarter ending 2018-09-30 was $28.33K.
- VERU INC. adjustments to additional paid in capital, other for the quarter ending 2018-06-30 was $56.66K.
- VERU INC. adjustments to additional paid in capital, other for fiscal 2019 was $101.98K, a 20.00% increase from fiscal 2018.
- VERU INC. adjustments to additional paid in capital, other for fiscal 2018 was $84.98K.
- VERU INC. adjustments to additional paid in capital, other for fiscal 2012 was -$2.18M.
- VERU INC. adjustments to additional paid in capital, other for fiscal 2010 was -$313.76K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2019-09-30 | $101.98K 10-K · filed 2019-12-12 | |||
| 2019-06-30 | $101.98K 10-Q · filed 2019-08-08 | |||
| 2018-09-30 | $28.33K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $84.98K derived: sum of 2 quarters · filed 2019-12-12 | $84.98K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $56.66K 10-Q · filed 2019-08-08 | $56.66K 10-Q · filed 2018-08-14 | ||
| 2012-09-30 | -$2.18M 10-K · filed 2013-12-03 | |||
| 2010-09-30 | -$313.76K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |